Webinar 1 - Weak Quality Management: Killing the Gains Achieved in Supply Chain Strengthening was held on 30 June 2026 and established the evidence base: substandard, falsified and unregistered medical products are a documented, measurable and recurring feature of African health supply chains, and quality can be lost at any point between manufacturer and patient.
Webinar 2 - Where Quality Breaks Down: Procurement, Warehousing, and Last Mile was held on 11 August 2026 and went inside the mechanism. Five practitioners traced where quality is actually lost across procurement, importing and freight, warehousing and distribution, and the last mile. The recurring finding was that quality rarely fails because a standard is absent. It fails because the standard is not documented, not audited, or not carried through to the stakeholder physically handling the product.
That finding sets the question for the third webinar. If operational failure is largely a failure of documentation, audit and transfer of accountability at the right time, then the governing question is institutional rather than technical: who sets the requirement, who verifies it, who is answerable when it is not met.
Webinar 3 maps the stakeholder and regulatory architecture around the supply chain, separates genuine regulatory progress from progress that is often overstated, and sets out what the national regulatory agencies and the African Medicines Agency (AMA) is mandated to do.
Summary
Objectives
• Map the stakeholders that hold a formal or de facto role in health product quality - national regulators, procurement agencies, ministries, customs and enforcement, regional economic communities, the AMA, WHO, donors and pooled procurers, standards bodies, professional associations, and logistics providers - and make explicit who is accountable for what
• Establish an accurate picture of regulatory progress: what WHO Global Benchmarking Tool (GBT) maturity levels do and do not certify, which reliance and work-sharing mechanisms exist in practice, and where they apply
• Identify the structural gaps: post-market surveillance capacity, the absence of direct licensing and inspection of logistics providers in most national frameworks, cross-border enforcement, and the distance between a regulation being gazetted and being enforced
• Set out the AMA mandate accurately - what it is designed to do, what remains a national competence, and what practitioners should realistically expect within the next three to five years
• Give practitioners a practical route into the system: how to verify a product with a regulator, how to report a suspected quality defect, what happens to that report, and what contractual levers exist where public enforcement is weak